Impact of Glucagon-Like Peptide-1 Agonists on Hepatocellular Carcinoma Risk and Management in Type 2 Diabetes Mellitus: A Scoping Review.

Cureus · 2025 · PMC12840817 · PMID 41607999

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

These studies still observed favorable liver-related outcomes, such as reductions in cirrhosis and hepatic decompensation, although these findings did not reach statistical significance [ 20 , 21 , 23 - 26 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.